The role of pregnancy on susceptibility and antibody dependent enhancement of immune cells for Zika virus infection

The role of pregnancy on susceptibility and antibody dependent enhancement of immune cells for Zika virus infection - Zika virus and pregnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50935

Enrollment

Registered

2021-03-30

Start date

2021-04-13

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zika virus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Pregnancy

Exclusion criteria

Exclusion criteria: Pregnancy complications

Design outcomes

Primary

Measure	Time frame
The main endpoints of this study are the ZIKV titers measured in the supernatant of infected PBMCs as well as the percentage of PBMCs that are infected with ZIKV.	—

Secondary

Measure	Time frame
The secondary endpoints of this study are the cytokines detected in the supernatant of infected PBMCs from pregnant women and non pregnant women.	—

Countries

Netherlands

Outcome results